THEMIS (Completed)
A multinational, randomised, double-blind, placebo-controlled trial to evaluate the effect of ticagrelor 90mg twice daily on the incidence of cardiovascular death, myocardial infarction or stroke in patients with type 2 diabetes mellitus
- Medicine
- ticagrelor
- Population
- Diabetes mellitus
- Phase
- III
- Starting year
- 2015
- More information
- ClinicalTrials.gov